Enzene Biosciences Ltd.
Clinical trials sponsored by Enzene Biosciences Ltd., explained in plain language.
-
New osteoporosis drug shows promise in Head-to-Head trial
Disease control CompletedThis study compared a new drug called Enzene denosumab (ENZ215) to the approved drug Prolia in 504 postmenopausal women with osteoporosis. The goal was to see if the new drug works as well at improving bone density and controlling bone breakdown over 12 months. The trial is compl…
Phase: PHASE3 • Sponsor: Enzene Biosciences Ltd. • Aim: Disease control
Last updated May 12, 2026 13:39 UTC
-
Healthy men help compare bone drug copies
Knowledge-focused CompletedThis study tested whether a new version of the bone drug denosumab (ENZ215) works the same as two approved versions (Prolia from Europe and the US). It involved 207 healthy adult male volunteers who received a single injection. The goal was to compare how the drug moves through t…
Phase: PHASE1 • Sponsor: Enzene Biosciences Ltd. • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:48 UTC